Terms: = Endocrine gland cancer AND FES, FPS, 2242, ENSG00000182511, P07332
47 results:
1. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
2. The Application of 18 F-fes PET in Clinical cancer Care : A Systematic Review.
Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
[TBL] [Abstract] [Full Text] [Related]
3. Autophagy fuels mitochondrial function through regulation of iron metabolism in pancreatic cancer.
Mukhopadhyay S; Encarnacion-Rosado J; Kimmelman AC
Autophagy; 2024 Apr; 20(4):963-964. PubMed ID: 37312426
[TBL] [Abstract] [Full Text] [Related]
4. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.
Gan Y; Liu T; Feng W; Wang L; Li LI; Ning Y
Oncol Res; 2023; 31(3):333-343. PubMed ID: 37305383
[TBL] [Abstract] [Full Text] [Related]
5. Development of the nonreceptor tyrosine kinase FER-targeting PROTACs as a potential strategy for antagonizing ovarian cancer cell motility and invasiveness.
Zhang Y; Xiong X; Sun R; Zhu X; Wang C; Jiang B; Yang X; Li D; Fan G
J Biol Chem; 2023 Jun; 299(6):104825. PubMed ID: 37196766
[TBL] [Abstract] [Full Text] [Related]
6. Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma.
Feng Z; Shao D; Cai Y; Bi R; Ju X; Chen D; Song C; Chen X; Li J; An N; Li Y; Zhou Q; Xiu Z; Zhu S; Wu X; Wen H
J Ovarian Res; 2023 Mar; 16(1):53. PubMed ID: 36922847
[TBL] [Abstract] [Full Text] [Related]
7. Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer.
Tesfay L; Paul BT; Hegde P; Brewer M; Habbani S; Jellison E; Moore T; Wu H; Torti SV; Torti FM
Sci Rep; 2022 Nov; 12(1):19936. PubMed ID: 36402786
[TBL] [Abstract] [Full Text] [Related]
8. An Anticancer Rhenium Tricarbonyl Targets Fe-S Cluster Biogenesis in Ovarian cancer Cells.
Neuditschko B; King AP; Huang Z; Janker L; Bileck A; Borutzki Y; Marker SC; Gerner C; Wilson JJ; Meier-Menches SM
Angew Chem Int Ed Engl; 2022 Oct; 61(43):e202209136. PubMed ID: 36004624
[TBL] [Abstract] [Full Text] [Related]
9. Effects of preoperative biliary drainage methods and time to postoperative complications after biliary drainage in periampullary tumors.
Subasi O; Ercan M; Aziret M; Biricik A; Kahraman YS; Altıntoprak F; Celebi F; Karaman K
Ann Ital Chir; 2022; 93():403-409. PubMed ID: 35758240
[TBL] [Abstract] [Full Text] [Related]
10. Endoscopic ultrasound-guided side-fenestrated needle biopsy sampling is sensitive for pancreatic neuroendocrine tumors but inadequate for tumor grading: a prospective study.
Appelstrand A; Bergstedt F; Elf AK; Fagman H; Hedenström P
Sci Rep; 2022 Apr; 12(1):5971. PubMed ID: 35396490
[TBL] [Abstract] [Full Text] [Related]
11. PET Imaging of Estrogen Receptors Using
Kumar M; Salem K; Jeffery JJ; Fowler AM
Methods Mol Biol; 2022; 2418():129-151. PubMed ID: 35119664
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of super-resolution on 50 pancreatic cancer patients with real-time cine MRI from 0.35T MRgRT.
Chun J; Lewis B; Ji Z; Shin JI; Park JC; Kim JS; Kim T
Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34375963
[TBL] [Abstract] [Full Text] [Related]
13. RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic cancer Cells.
Swami P; Thiyagarajan S; Vidger A; Indurthi VSK; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086527
[TBL] [Abstract] [Full Text] [Related]
14. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
Li N; Ming X; Li Z
Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
[TBL] [Abstract] [Full Text] [Related]
15. Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma
Novera W; Lee ZW; Nin DS; Dai MZ; Binte Idres S; Wu H; Damen JMA; Tan TZ; Sim AYL; Long YC; Wu W; Huang RY; Deng LW
Antioxid Redox Signal; 2020 Dec; 33(17):1191-1208. PubMed ID: 32336105
[No Abstract] [Full Text] [Related]
16. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract] [Full Text] [Related]
17. Identification of fes as a Novel Radiosensitizing Target in Human cancers.
Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
[TBL] [Abstract] [Full Text] [Related]
18. A pilot study examining Toronto-area family physician perspectives on thyroid neoplasm evaluation.
Kundra A; Goldstein DP; Wintemute K; Ghai S; Tsang RW; Gupta K; Mutasingwa DR; Weissberger J; Huszti E; Brown P; Jiang H; Sawka AM
J Otolaryngol Head Neck Surg; 2019 May; 48(1):24. PubMed ID: 31146769
[TBL] [Abstract] [Full Text] [Related]
19. Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer.
Tseng JH; Cowan RA; Afonso AM; Zhou Q; Iasonos A; Ali N; Thompson E; Sonoda Y; O'Cearbhaill RE; Chi DS; Abu-Rustum NR; Long Roche K
Gynecol Oncol; 2018 Nov; 151(2):287-293. PubMed ID: 30185381
[TBL] [Abstract] [Full Text] [Related]
20. Non-
Kalshetty A; Basu S
PET Clin; 2018 Apr; 13(2):239-248. PubMed ID: 29482752
[TBL] [Abstract] [Full Text] [Related]
[Next]
